Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Licensing and collaboration revenue	$ 4,192	$ 1,476
Operating expenses:
Research and development	22,579	12,327
General and administrative	10,044	5,113
Total operating expenses	32,623	17,440
Loss from operations	(28,431)	(15,964)
Other income (expense):
Change in fair value of equity securities	(16)
Change in fair value of the MSKCC success payments liability	1,052
Other income - net	698	69
Total other income (expense)	1,734	1,653
Net loss	(26,697)	(14,311)
Net unrealized loss on available-for-sale marketable securities, net of tax	(492)
Net comprehensive loss	$ (27,189)	$ (14,311)
Earnings Per Share, Basic	$ (0.44)	$ (1.39)
Earnings Per Share, Diluted	$ (0.44)	$ (1.39)
Weighted Average Number of Shares Outstanding, Basic	60,757,689	10,261,770
Weighted Average Number of Shares Outstanding, Diluted	60,757,689	10,261,770